Statistics for Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-naïve and anti-VEGF pretreated patients
Total visits
| views | |
|---|---|
| Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-naïve and anti-VEGF pretreated patients | 1 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 1 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:67eda753-1be7-4310-a9ea-dbeb362ca846 | 17 |
| java.util.UUID:7bc7bfaa-55ff-4799-be7f-a841b4f1840f | 15 |
| java.util.UUID:ecd0b5c1-6e01-49d7-b994-def1ea27a929 | 8 |
Top country views
| views | |
|---|---|
| United States | 1 |